aydın, g. Et Al. 2017. Tenofovir versus tenofovir plus entecavir for chronic hepatitis b in patients with previous nucleos(t)ide treatment failure.. ILC2017-RS-3845. International Liver Congress™ 2017- 52st annual meeting of the European Association for the Study of the Liver (EASL) , (Amsterdam, Netherlands).

aydın, g., karadağ, f., KADER, Ç., korkmaz, F., tülek, n., SÜER, H. K., ... SAYAN, M.(2017). Tenofovir versus tenofovir plus entecavir for chronic hepatitis b in patients with previous nucleos(t)ide treatment failure. . ILC2017-RS-3845. International Liver Congress™ 2017- 52st annual meeting of the European Association for the Study of the Liver (EASL), Amsterdam, Netherlands

aydın, güle Et Al. "Tenofovir versus tenofovir plus entecavir for chronic hepatitis b in patients with previous nucleos(t)ide treatment failure.," ILC2017-RS-3845. International Liver Congress™ 2017- 52st annual meeting of the European Association for the Study of the Liver (EASL), Amsterdam, Netherlands, 2017

aydın, güle Et Al. "Tenofovir versus tenofovir plus entecavir for chronic hepatitis b in patients with previous nucleos(t)ide treatment failure.." ILC2017-RS-3845. International Liver Congress™ 2017- 52st annual meeting of the European Association for the Study of the Liver (EASL) , Amsterdam, Netherlands, 2017

aydın, g. Et Al. (2017) . "Tenofovir versus tenofovir plus entecavir for chronic hepatitis b in patients with previous nucleos(t)ide treatment failure.." ILC2017-RS-3845. International Liver Congress™ 2017- 52st annual meeting of the European Association for the Study of the Liver (EASL) , Amsterdam, Netherlands.

@conferencepaper{conferencepaper, author={güle aydın Et Al. }, title={Tenofovir versus tenofovir plus entecavir for chronic hepatitis b in patients with previous nucleos(t)ide treatment failure.}, congress name={ILC2017-RS-3845. International Liver Congress™ 2017- 52st annual meeting of the European Association for the Study of the Liver (EASL)}, city={Amsterdam}, country={Netherlands}, year={2017}}